NSCLC, early stageNeoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
暂无分享,去创建一个
G. Rosner | V. Velculescu | J. Taube | J. Wolchok | E. Gabrielson | C. Georgiades | V. Anagnostou | M. Hellmann | J. Chaft | D. Pardoll | Stephen C. Yang | S. Topalian | T. Merghoub | J. Naidoo | P. Forde | J. Brahmer | Kellie N. Smith | T. Cottrell | F. Verde | R. Battafarano